Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells

Yoshihiko Hirohashi, Toshihiko Torigoe, Itaru Hirai, Yasuaki Tamura, Munehide Nakatsugawa, Yuuji Inoue, Takayuki Kanaseki, Kenjiro Kamiguchi, Hideyuki Ikeda, Aya Sasaki, Noboru Yamanaka, Noriyuki Sato

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Cytotoxic T lymphocytes (CTLs) play an essential role in immunological responses for tumor rejection. In the past decade, many tumor-associated antigens (TAAs) have been identified predominantly in melanomas. Several clinical trials based on such antigenic peptides with or without adjuvants brought about partially favorable results, suggesting that identification of more immunogenic TAAs is needed. We show here the successful establishment of human leukocyte antigen (HLA)-A24-restricted CTL (TcLHK2 line1) from a pleural effusion of lung cancer patient, using B7.1 (CD80) transduced autologous lung cancer cells as an antigen-presenting cell (APC). TcLHK2 line1 recognized autologous lung adenocarcinoma cell line LHK2 in an HLA-A24-restricted fashion. Moreover, this CTL line also recognized allogeneic HLA-A24-positive lung adenocarcinoma cell line, gastric carcinoma cell line and melanoma cell line. These data raise the possibility that co-stimulatory molecule B7.1 (CD80) plays important role to overcome the immunological tolerance. Furthermore, TcLHK2 line1 is a useful tool for the identification of widely expressed shared antigens restricted by HLA-A24. Further analysis of this CTL and autologous cancer cell line will bring about novel TAAs.

Original languageEnglish
Pages (from-to)128-132
Number of pages5
JournalExperimental and Molecular Pathology
Volume88
Issue number1
DOIs
Publication statusPublished - 2010 Feb
Externally publishedYes

Fingerprint

T-cells
Cytotoxic T-Lymphocytes
HLA Antigens
Cells
Antigens
Neoplasm Antigens
Cell Line
Molecules
Tumors
Neoplasms
Melanoma
Lung Neoplasms
Antigen-Presenting Cells
Pleural Effusion
Stomach
Clinical Trials
Carcinoma
Peptides

Keywords

  • Adenocarcinoma
  • B7.1 (CD80)
  • CTL
  • HLA-A24
  • Lung cancer
  • Tolerance

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Cite this

Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells. / Hirohashi, Yoshihiko; Torigoe, Toshihiko; Hirai, Itaru; Tamura, Yasuaki; Nakatsugawa, Munehide; Inoue, Yuuji; Kanaseki, Takayuki; Kamiguchi, Kenjiro; Ikeda, Hideyuki; Sasaki, Aya; Yamanaka, Noboru; Sato, Noriyuki.

In: Experimental and Molecular Pathology, Vol. 88, No. 1, 02.2010, p. 128-132.

Research output: Contribution to journalArticle

Hirohashi, Y, Torigoe, T, Hirai, I, Tamura, Y, Nakatsugawa, M, Inoue, Y, Kanaseki, T, Kamiguchi, K, Ikeda, H, Sasaki, A, Yamanaka, N & Sato, N 2010, 'Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells', Experimental and Molecular Pathology, vol. 88, no. 1, pp. 128-132. https://doi.org/10.1016/j.yexmp.2009.09.021
Hirohashi, Yoshihiko ; Torigoe, Toshihiko ; Hirai, Itaru ; Tamura, Yasuaki ; Nakatsugawa, Munehide ; Inoue, Yuuji ; Kanaseki, Takayuki ; Kamiguchi, Kenjiro ; Ikeda, Hideyuki ; Sasaki, Aya ; Yamanaka, Noboru ; Sato, Noriyuki. / Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells. In: Experimental and Molecular Pathology. 2010 ; Vol. 88, No. 1. pp. 128-132.
@article{27df249d426347d9b265932cf8333ae0,
title = "Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells",
abstract = "Cytotoxic T lymphocytes (CTLs) play an essential role in immunological responses for tumor rejection. In the past decade, many tumor-associated antigens (TAAs) have been identified predominantly in melanomas. Several clinical trials based on such antigenic peptides with or without adjuvants brought about partially favorable results, suggesting that identification of more immunogenic TAAs is needed. We show here the successful establishment of human leukocyte antigen (HLA)-A24-restricted CTL (TcLHK2 line1) from a pleural effusion of lung cancer patient, using B7.1 (CD80) transduced autologous lung cancer cells as an antigen-presenting cell (APC). TcLHK2 line1 recognized autologous lung adenocarcinoma cell line LHK2 in an HLA-A24-restricted fashion. Moreover, this CTL line also recognized allogeneic HLA-A24-positive lung adenocarcinoma cell line, gastric carcinoma cell line and melanoma cell line. These data raise the possibility that co-stimulatory molecule B7.1 (CD80) plays important role to overcome the immunological tolerance. Furthermore, TcLHK2 line1 is a useful tool for the identification of widely expressed shared antigens restricted by HLA-A24. Further analysis of this CTL and autologous cancer cell line will bring about novel TAAs.",
keywords = "Adenocarcinoma, B7.1 (CD80), CTL, HLA-A24, Lung cancer, Tolerance",
author = "Yoshihiko Hirohashi and Toshihiko Torigoe and Itaru Hirai and Yasuaki Tamura and Munehide Nakatsugawa and Yuuji Inoue and Takayuki Kanaseki and Kenjiro Kamiguchi and Hideyuki Ikeda and Aya Sasaki and Noboru Yamanaka and Noriyuki Sato",
year = "2010",
month = "2",
doi = "10.1016/j.yexmp.2009.09.021",
language = "English",
volume = "88",
pages = "128--132",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Establishment of shared antigen reactive cytotoxic T lymphocyte using co-stimulatory molecule introduced autologous cancer cells

AU - Hirohashi, Yoshihiko

AU - Torigoe, Toshihiko

AU - Hirai, Itaru

AU - Tamura, Yasuaki

AU - Nakatsugawa, Munehide

AU - Inoue, Yuuji

AU - Kanaseki, Takayuki

AU - Kamiguchi, Kenjiro

AU - Ikeda, Hideyuki

AU - Sasaki, Aya

AU - Yamanaka, Noboru

AU - Sato, Noriyuki

PY - 2010/2

Y1 - 2010/2

N2 - Cytotoxic T lymphocytes (CTLs) play an essential role in immunological responses for tumor rejection. In the past decade, many tumor-associated antigens (TAAs) have been identified predominantly in melanomas. Several clinical trials based on such antigenic peptides with or without adjuvants brought about partially favorable results, suggesting that identification of more immunogenic TAAs is needed. We show here the successful establishment of human leukocyte antigen (HLA)-A24-restricted CTL (TcLHK2 line1) from a pleural effusion of lung cancer patient, using B7.1 (CD80) transduced autologous lung cancer cells as an antigen-presenting cell (APC). TcLHK2 line1 recognized autologous lung adenocarcinoma cell line LHK2 in an HLA-A24-restricted fashion. Moreover, this CTL line also recognized allogeneic HLA-A24-positive lung adenocarcinoma cell line, gastric carcinoma cell line and melanoma cell line. These data raise the possibility that co-stimulatory molecule B7.1 (CD80) plays important role to overcome the immunological tolerance. Furthermore, TcLHK2 line1 is a useful tool for the identification of widely expressed shared antigens restricted by HLA-A24. Further analysis of this CTL and autologous cancer cell line will bring about novel TAAs.

AB - Cytotoxic T lymphocytes (CTLs) play an essential role in immunological responses for tumor rejection. In the past decade, many tumor-associated antigens (TAAs) have been identified predominantly in melanomas. Several clinical trials based on such antigenic peptides with or without adjuvants brought about partially favorable results, suggesting that identification of more immunogenic TAAs is needed. We show here the successful establishment of human leukocyte antigen (HLA)-A24-restricted CTL (TcLHK2 line1) from a pleural effusion of lung cancer patient, using B7.1 (CD80) transduced autologous lung cancer cells as an antigen-presenting cell (APC). TcLHK2 line1 recognized autologous lung adenocarcinoma cell line LHK2 in an HLA-A24-restricted fashion. Moreover, this CTL line also recognized allogeneic HLA-A24-positive lung adenocarcinoma cell line, gastric carcinoma cell line and melanoma cell line. These data raise the possibility that co-stimulatory molecule B7.1 (CD80) plays important role to overcome the immunological tolerance. Furthermore, TcLHK2 line1 is a useful tool for the identification of widely expressed shared antigens restricted by HLA-A24. Further analysis of this CTL and autologous cancer cell line will bring about novel TAAs.

KW - Adenocarcinoma

KW - B7.1 (CD80)

KW - CTL

KW - HLA-A24

KW - Lung cancer

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=74749083042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74749083042&partnerID=8YFLogxK

U2 - 10.1016/j.yexmp.2009.09.021

DO - 10.1016/j.yexmp.2009.09.021

M3 - Article

C2 - 19818766

AN - SCOPUS:74749083042

VL - 88

SP - 128

EP - 132

JO - Experimental and Molecular Pathology

JF - Experimental and Molecular Pathology

SN - 0014-4800

IS - 1

ER -